세계의 투약 관리 시장 : 예측(2025-2030년)

The Global Medication Management Market is set to grow from USD 3.795 billion in 2025 to USD 6.851 billion by 2030, driven by a 12.54% CAGR.

The medication management market is a critical segment of healthcare, focusing on patient-centered systems to optimize safe, effective, and appropriate drug therapy. These systems streamline clinical operations, ensuring accurate medication administration and adherence. The market is driven by the rise of complex therapies, increasing chronic disease prevalence, and technological advancements, though high implementation costs pose challenges.

This research examines current trends in demand, supply, and sales, alongside recent developments shaping the medication management market. It provides a comprehensive analysis of key drivers, restraints, and opportunities, detailing industry trends, policies, and regulations across geographical regions to equip stakeholders with insights into the regulatory framework and market dynamics.

Competitive intelligence identifies major industry players and their revenue contributions, derived from extensive secondary research, including industry association studies, analyst reports, investor presentations, press releases, and journals. Market size for the overall sector and key segments was determined using bottom-up and top-down methodologies, validated with primary inputs from stakeholders in the global medication management value chain. Comprehensive market engineering integrated data from diverse sources and proprietary datasets, employing data triangulation for accurate market breakdown and forecasting. Insights are presented through analytical narratives, charts, and graphics for efficient comprehension. The global market was valued at approximately USD 2.6 billion in 2024 and is projected to reach USD 5.8 billion by 2030, growing at a CAGR of 14.3%. Key players profiled include Genoa Healthcare, Becton, Dickinson and Company, Sinfonia Rx (A Tabula Rasa Healthcare Company), CSAM Health AS, Honeywell International Inc., GE Healthcare, Talyst, LLC, Cerner Corporation, OptumRx, and McKesson Corporation.

Key Highlights

• Complex Therapies: Emergence of advanced therapies drives demand for efficient medication management systems.
• Chronic Diseases: Rising prevalence of chronic conditions, affecting 60% of adults globally in 2024, fuels market growth.
• Technological Advancements: Innovations like remote medication management and rosette systems create growth opportunities.
• Cost Barriers: High implementation and maintenance costs hinder adoption, particularly for smaller healthcare facilities.

Growth Drivers

The rise in chronic diseases, with global cases increasing by 5% in 2024, necessitates robust medication management to ensure adherence and safety. An aging population, projected to reach 1.5 billion by 2050, increases demand for systems to manage complex medication regimens. Technological advancements, such as remote medication management systems introduced by McKesson in 2024, enhance patient monitoring and operational efficiency. Growing healthcare IT adoption, particularly in North America, with a 10% increase in digital health investments in 2024, supports market expansion.

Restraints

High implementation costs, averaging USD 500,000 for comprehensive systems, and ongoing maintenance expenses limit adoption in smaller healthcare settings. Integration challenges with legacy healthcare systems increase deployment complexity. Limited technical expertise in emerging markets further restricts scalability.

Segmentation Analysis

By Software Type: Inventory management systems dominate with a 35% share in 2024, driven by their role in minimizing resource wastage. Clinical decision support systems grow rapidly for enhanced patient safety.

By Delivery Mode: Cloud-based solutions lead, offering scalability and remote access, while on-premise systems persist in secure environments.

By End-User: Hospitals command the largest share, with pharmacies and homecare settings expanding due to telehealth trends.

Regional Analysis

North America holds a 42% market share in 2024, driven by high IT adoption in the U.S. healthcare sector and investments of USD 15 billion in digital health. Asia Pacific grows at a 16% CAGR, fueled by rising chronic disease prevalence and healthcare modernization in China and India. Europe advances through supportive digital health policies.

This report equips industry experts with critical insights into market trends, regulatory landscapes, and competitive dynamics. It highlights opportunities in advanced therapies and digital health integration while addressing cost and integration challenges. The rigorous methodology, blending primary and secondary data, ensures reliable projections, enabling stakeholders to navigate complexities and prioritize investments in this essential healthcare sector.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Software Type

• Computerized Physician Order Entry (CPOE)
• Clinical Decision Support Systems (CDSS)
• Electronic Medication Administration Records (eMAR)
• Inventory & Dispensing Management

By Delivery Mode

• On-Premise
• Cloud-Based

By End-User

• Hospitals & Clinics
• Pharmacies
• Ambulatory Surgical Centers
• Long-Term Care Facilities

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Italy
• Others
• Middle East & Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL MEDICATION MANAGEMENT MARKET BY SOFTWARE TYPE

• 5.1. Introduction
• 5.2. Computerized Physician Order Entry (CPOE)
• 5.3. Clinical Decision Support Systems (CDSS)
• 5.4. Electronic Medication Administration Records (eMAR)
• 5.5. Inventory & Dispensing Management

6. GLOBAL MEDICATION MANAGEMENT MARKET BY DELIVERY MODE

• 6.1. Introduction
• 6.2. On-Premise
• 6.3. Cloud-Based

7. GLOBAL MEDICATION MANAGEMENT MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals & Clinics
• 7.3. Pharmacies
• 7.4. Ambulatory Surgical Centers
• 7.5. Long-Term Care Facilities

8. GLOBAL MEDICATION MANAGEMENT MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Software Type
  • 8.2.2. By Delivery Mode
  • 8.2.3. By End-User
  • 8.2.4. By Country
    • 8.2.4.1. United States
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Software Type
  • 8.3.2. By Delivery Mode
  • 8.3.3. By End-User
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Software Type
  • 8.4.2. By Delivery Mode
  • 8.4.3. By End-User
  • 8.4.4. By Country
    • 8.4.4.1. United Kingdom
    • 8.4.4.2. Germany
    • 8.4.4.3. France
    • 8.4.4.4. Italy
    • 8.4.4.5. Others
• 8.5. Middle East & Africa
  • 8.5.1. By Software Type
  • 8.5.2. By Delivery Mode
  • 8.5.3. By End-User
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. UAE
    • 8.5.4.3. Others
• 8.6. Asia Pacific
  • 8.6.1. By Software Type
  • 8.6.2. By Delivery Mode
  • 8.6.3. By End-User
  • 8.6.4. By Country
    • 8.6.4.1. Japan
    • 8.6.4.2. China
    • 8.6.4.3. India
    • 8.6.4.4. South Korea
    • 8.6.4.5. Taiwan
    • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Optum United Health
• 10.2. Becton, Dickinson and Company
• 10.3. Omda AS
• 10.4. Honeywell International Inc.
• 10.5. GE Healthcare Technologies, Inc.
• 10.6. Talyst, LLC (Swisslog Healthcare)
• 10.7. Oracle Health
• 10.8. McKesson Corporation
• 10.9. Omnicell, Inc.
• 10.10. Cardinal Health Inc.
• 10.11. Baxter International, Inc.

11. RESEARCH METHODOLOGY